Medicamen Biotech Limited (NSE:MEDICAMEQ)

Medicamen Biotech Revenue

Medicamen Biotech had revenue of 474.43M INR in the quarter ending December 31, 2025, with 5.10% growth. This brings the company's revenue in the last twelve months to 1.72B, down -4.52% year-over-year. In the fiscal year ending March 31, 2025, Medicamen Biotech had annual revenue of 1.68B, down -6.56%.

• Revenue (ttm): 1.72B
• Revenue Growth: -4.52%
• P/S Ratio: 1.67
• Revenue / Employee: 4.58M
• Employees: 376
• Market Cap: 2.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.68B	-117.59M	-6.56%
Mar 31, 2024	1.79B	384.39M	27.29%
Mar 31, 2023	1.41B	254.22M	22.02%
Mar 31, 2022	1.15B	27.29M	2.42%
Mar 31, 2021	1.13B	-128.18M	-10.21%